2015-2027 Global Neurological Disorder Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 124 pages | ID: 2F495776C453EN
Maia Research

Abstracts

The worldwide market for Neurological Disorder Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
AstraZeneca
Bayer AG
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Novartis AG
Boehringer Ingelheim GmbH
Merck & Co.
Teva Pharmaceutical Industries Ltd.

Major Types Covered
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others

Major Applications Covered
Hospital
Clinic
Home

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Neurological Disorder Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Neurological Disorder Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE NEUROLOGICAL DISORDER DRUGS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET-SEGMENTATION BY TYPE

5.1 Antipsychotic
5.2 Hypnotic & Sedative
5.3 Analgesics
5.4 Anticoagulants
5.5 Others

6 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET-SEGMENTATION BY APPLICATION

6.1 Hospital
6.2 Clinic
6.3 Home

7 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 AstraZeneca
  8.1.1 AstraZeneca Profile
  8.1.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
  8.1.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.2 Bayer AG
  8.2.1 Bayer AG Profile
  8.2.2 Bayer AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Bayer AG Product/Solution Launches and Enhancements Analysis
  8.2.4 Bayer AG Business Overview/Recent Development/Acquisitions
8.3 GlaxoSmithKline plc
  8.3.1 GlaxoSmithKline plc Profile
  8.3.2 GlaxoSmithKline plc Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 GlaxoSmithKline plc Product/Solution Launches and Enhancements Analysis
  8.3.4 GlaxoSmithKline plc Business Overview/Recent Development/Acquisitions
8.4 F. Hoffmann-La Roche Ltd.
  8.4.1 F. Hoffmann-La Roche Ltd. Profile
  8.4.2 F. Hoffmann-La Roche Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 F. Hoffmann-La Roche Ltd. Product/Solution Launches and Enhancements Analysis
  8.4.4 F. Hoffmann-La Roche Ltd. Business Overview/Recent Development/Acquisitions
8.5 Novartis AG
  8.5.1 Novartis AG Profile
  8.5.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Novartis AG Product/Solution Launches and Enhancements Analysis
  8.5.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.6 Boehringer Ingelheim GmbH
  8.6.1 Boehringer Ingelheim GmbH Profile
  8.6.2 Boehringer Ingelheim GmbH Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Boehringer Ingelheim GmbH Product/Solution Launches and Enhancements Analysis
  8.6.4 Boehringer Ingelheim GmbH Business Overview/Recent Development/Acquisitions
8.7 Merck & Co.
  8.7.1 Merck & Co. Profile
  8.7.2 Merck & Co. Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Merck & Co. Product/Solution Launches and Enhancements Analysis
  8.7.4 Merck & Co. Business Overview/Recent Development/Acquisitions
8.8 Teva Pharmaceutical Industries Ltd.
  8.8.1 Teva Pharmaceutical Industries Ltd. Profile
  8.8.2 Teva Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Teva Pharmaceutical Industries Ltd. Product/Solution Launches and Enhancements Analysis
  8.8.4 Teva Pharmaceutical Industries Ltd. Business Overview/Recent Development/Acquisitions

9 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Neurological Disorder Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Neurological Disorder Drugs Production Analysis from 2015-2020
10.4 North America Neurological Disorder Drugs Consumption Analysis from 2015-2020
10.5 North America Neurological Disorder Drugs Import and Export from 2015-2020
10.6 North America Neurological Disorder Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Neurological Disorder Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Neurological Disorder Drugs by Country (United States, Canada)
  10.8.1 North America Neurological Disorder Drugs Sales by Country (2015-2020)
  10.8.2 North America Neurological Disorder Drugs Consumption Value by Country (2015-2020)
10.9 North America Neurological Disorder Drugs Market PEST Analysis

11 EUROPE

11.1 Europe Neurological Disorder Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Neurological Disorder Drugs Production Analysis from 2015-2020
11.4 Europe Neurological Disorder Drugs Consumption Analysis from 2015-2020
11.5 Europe Neurological Disorder Drugs Import and Export from 2015-2020
11.6 Europe Neurological Disorder Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Neurological Disorder Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Neurological Disorder Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Neurological Disorder Drugs Sales by Country (2015-2020)
  11.8.2 Europe Neurological Disorder Drugs Consumption Value by Country (2015-2020)
11.9 Europe Neurological Disorder Drugs Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Neurological Disorder Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Neurological Disorder Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Neurological Disorder Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Neurological Disorder Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Neurological Disorder Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Neurological Disorder Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Neurological Disorder Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Neurological Disorder Drugs Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Neurological Disorder Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Neurological Disorder Drugs Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Neurological Disorder Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Neurological Disorder Drugs Production Analysis from 2015-2020
13.4 Latin America Neurological Disorder Drugs Consumption Analysis from 2015-2020
13.5 Latin America Neurological Disorder Drugs Import and Export from 2015-2020
13.6 Latin America Neurological Disorder Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Neurological Disorder Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Neurological Disorder Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Neurological Disorder Drugs Sales by Country (2015-2020)
  13.8.2 Latin America Neurological Disorder Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Neurological Disorder Drugs Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Neurological Disorder Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Neurological Disorder Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Neurological Disorder Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Neurological Disorder Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Neurological Disorder Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Neurological Disorder Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Neurological Disorder Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Neurological Disorder Drugs Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Neurological Disorder Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Neurological Disorder Drugs Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Neurological Disorder Drugs Market from 2020-2027 Segment by Region
15.2 Global Neurological Disorder Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Neurological Disorder Drugs Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Neurological Disorder Drugs Market Value ($) and Growth Rate of Neurological Disorder Drugs from 2015-2027
Global Neurological Disorder Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Neurological Disorder Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Neurological Disorder Drugs Picture
Table Product Specifications of Neurological Disorder Drugs
Table Driving Factors for this Market
Table Industry News of Neurological Disorder Drugs Market
Figure Value Chain Status of Neurological Disorder Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Neurological Disorder Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Neurological Disorder Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Antipsychotic of Neurological Disorder Drugs
Figure Hypnotic & Sedative of Neurological Disorder Drugs
Figure Analgesics of Neurological Disorder Drugs
Figure Anticoagulants of Neurological Disorder Drugs
Figure Others of Neurological Disorder Drugs
Table Global Neurological Disorder Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Neurological Disorder Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospital of Neurological Disorder Drugs
Figure Clinic of Neurological Disorder Drugs
Figure Home of Neurological Disorder Drugs
Table Global Neurological Disorder Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Neurological Disorder Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Neurological Disorder Drugs
Figure Online Channel of Neurological Disorder Drugs
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer AG Sales and Growth Rate from 2015-2020
Figure Bayer AG Revenue ($) and Global Market Share from 2015-2020
Table Bayer AG Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline plc Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline plc Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline plc Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table F. Hoffmann-La Roche Ltd. Profile (Company Name, Plants Distribution, Sales Region)
Figure F. Hoffmann-La Roche Ltd. Sales and Growth Rate from 2015-2020
Figure F. Hoffmann-La Roche Ltd. Revenue ($) and Global Market Share from 2015-2020
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim GmbH Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim GmbH Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim GmbH Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co. Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co. Sales and Growth Rate from 2015-2020
Figure Merck & Co. Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co. Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Teva Pharmaceutical Industries Ltd. Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva Pharmaceutical Industries Ltd. Sales and Growth Rate from 2015-2020
Figure Teva Pharmaceutical Industries Ltd. Revenue ($) and Global Market Share from 2015-2020
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Neurological Disorder Drugs Production Value ($) by Region from 2015-2020
Table Global Neurological Disorder Drugs Production Value Share by Region from 2015-2020
Table Global Neurological Disorder Drugs Production by Region from 2015-2020
Table Global Neurological Disorder Drugs Consumption Value ($) by Region from 2015-2020
Table Global Neurological Disorder Drugs Consumption by Region from 2015-2020
Table North America Neurological Disorder Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Neurological Disorder Drugs Import and Export from 2015-2020
Table North America Neurological Disorder Drugs Value ($) by Type (2015-2020)
Table North America Neurological Disorder Drugs Production by Type (2015-2020)
Table North America Neurological Disorder Drugs Consumption by Application (2015-2020)
Table North America Neurological Disorder Drugs Consumption by Country (2015-2020)
Table North America Neurological Disorder Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Neurological Disorder Drugs Market PEST Analysis
Table Europe Neurological Disorder Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Neurological Disorder Drugs Import and Export from 2015-2020
Table Europe Neurological Disorder Drugs Value ($) by Type (2015-2020)
Table Europe Neurological Disorder Drugs Production by Type (2015-2020)
Table Europe Neurological Disorder Drugs Consumption by Application (2015-2020)
Table Europe Neurological Disorder Drugs Consumption by Country (2015-2020)
Table Europe Neurological Disorder Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Neurological Disorder Drugs Market PEST Analysis
Table Asia-Pacific Neurological Disorder Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Neurological Disorder Drugs Import and Export from 2015-2020
Table Asia-Pacific Neurological Disorder Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Neurological Disorder Drugs Production by Type (2015-2020)
Table Asia-Pacific Neurological Disorder Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Neurological Disorder Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Neurological Disorder Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Neurological Disorder Drugs Market PEST Analysis
Table Latin America Neurological Disorder Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Neurological Disorder Drugs Import and Export from 2015-2020
Table Latin America Neurological Disorder Drugs Value ($) by Type (2015-2020)
Table Latin America Neurological Disorder Drugs Production by Type (2015-2020)
Table Latin America Neurological Disorder Drugs Consumption by Application (2015-2020)
Table Latin America Neurological Disorder Drugs Consumption by Country (2015-2020)
Table Latin America Neurological Disorder Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Neurological Disorder Drugs Market PEST Analysis
Table Middle East & Africa Neurological Disorder Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Neurological Disorder Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Neurological Disorder Drugs Import and Export from 2015-2020
Table Middle East & Africa Neurological Disorder Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Neurological Disorder Drugs Production by Type (2015-2020)
Table Middle East & Africa Neurological Disorder Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Neurological Disorder Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Neurological Disorder Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Neurological Disorder Drugs Market PEST Analysis
Table Global Neurological Disorder Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Disorder Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Disorder Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Neurological Disorder Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Neurological Disorder Drugs Consumption and Growth Rate Forecast by Application (2020-2027)